Search Browse Earnings

Q BioMed Inc.

OTC:QBIO

Pharmaceutical Preparations·NEW YORK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Corin Denis

Revenue

$195,597

+552.0% YoY

FY 2022

Adj. EBITDA

—

Net Income

-$8.2M

-4213.0% margin

FY 2022

EPS (Diluted)

-$0.33

FY 2022

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$2.7M

FY 2020

Total Debt

$3.5M

FY 2020

Net Debt

$815,959

FY 2020

Enterprise Value

—

Debt / EBITDA

—

EV / EBITDA

—

Employees

—